K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRα in colorectal cancer

International Journal of Colorectal Disease

Volumn 25, Issue 2, 2010, Pages 181-186

  Schimanski, Carl C ^a   Zimmermann, Tim ^a   Schmidtmann, Irene ^b   Gockel, Ines ^a   Lang, Hauke ^a   Galle, Peter R ^a   Moehler, Markus ^a   Berger, Martin R ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

EGFR; K ras mutation; PDGFR; Receptor tyrosine kinases; VEGFR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

AGED; ARTICLE; CODON; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; CODON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MUTATION; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77649237043     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0843-7     Document Type: Article

References (27)

1. RT Greenlee T Murray S Bolden PA Wingo 2000 Cancer statistics, 2000 CA Cancer J Clin 50 7 33 10.3322/canjclin.50.1.7 1:STN:280:DC%2BD3c7pvFWrug%3D%3D 10735013
2. HK Weir MJ Thun BF Hankey, et al. 2003 Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 1276 1299 12953083
3. DA August RT Ottow PH Sugarbaker 1984 Clinical perspective of human colorectal cancer metastasis Cancer Metastasis Rev 3 303 324 10.1007/BF00051457 1:STN:280:DyaL2M%2FpvFSmtA%3D%3D 6394125
4. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 767 10.1016/0092-8674(90)90186-I 1:CAS:528:DyaK3cXktlyhtrg%3D 2188735 (Pubitemid 20185636)
5. KR Cho B Vogelstein 1992 Suppressor gene alterations in the colorectal adenoma-carcinoma sequence J Cell Biochem Suppl 16G 137 141 10.1002/jcb. 240501124 1:STN:280:DyaK3s7gvVOmtA%3D%3D 1469893
6. B Vogelstein KW Kinzler 1993 The multistep nature of cancer Trends Genet 9 138 141 10.1016/0168-9525(93)90209-Z 1:STN:280:DyaK3s3ps1yrtw%3D%3D 8516849 (Pubitemid 23098782)
7. G Smith FA Carey J Beattie, et al. 2002 Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer Proc Natl Acad Sci U S A 99 9433 9438 10.1073/pnas.122612899 1:CAS:528:DC%2BD38XlsVGgt78%3D 12093899 (Pubitemid 34764631)
8. E Li K Hristova 2006 Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies Biochemistry 45 6241 6251 10.1021/bi060609y 1:CAS:528:DC%2BD28XktVSksrs%3D 16700535 (Pubitemid 43787791)
9. C Mobius HJ Stein I Becker, et al. 2003 The "angiogenic switch" in the progression from Barrett's metaplasia to esophageal adenocarcinoma Eur J Surg Oncol 29 890 894 10.1016/j.ejso.2003.07.002 1:STN:280: DC%2BD3srksF2mtg%3D%3D 14624783 (Pubitemid 37493289)
10. XE Liu XD Sun JM Wu 2004 Expression and significance of VEGF-C and FLT-4 in gastric cancer World J Gastroenterol 10 352 355 1:CAS:528: DC%2BD2cXitVyktbg%3D 14760756
11. Y Yonemura Y Endo K Tabata, et al. 2005 Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer Int J Clin Oncol 10 318 327 10.1007/s10147-005-0508-7 1:CAS:528:DC%2BD2MXhtFCrtbzE 16247658 (Pubitemid 41507205)
12. Y Takahashi KR Cleary M Mai Y Kitadai CD Bucana LM Ellis 1996 Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer Clin Cancer Res 2 1679 1684 1:STN:280:DyaK1M%2FjsFWqtA%3D%3D 9816116
13. A Tokunaga M Onda T Okuda, et al. 1995 Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer Cancer 75 1418 1425 10.1002/1097-0142(19950315)75:6+<1418::AID-CNCR2820751505>3. 0.CO;2-Y 1:STN:280:DyaK2M7ps1Wmuw%3D%3D 7889468
14. KL Wang TT Wu IS Choi, et al. 2007 Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome Cancer 109 658 667 10.1002/cncr.22445 1:CAS:528: DC%2BD2sXis1Smt74%3D 17211865 (Pubitemid 46233226)
15. D Drescher M Moehler I Gockel, et al. 2007 Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma-a rationale for a molecular targeting strategy? World J Gastroenterol 13 3605 3609 1:CAS:528: DC%2BD2sXpsFKksrk%3D 17659711
16. CC Schimanski U Linnemann MR Berger 1999 Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver Cancer Res 59 5169 5175 1:CAS:528:DyaK1MXmvFels7Y%3D 10537293
17. WS Argraves CJ Drake 2005 Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice Anat Rec A Discov Mol Cell Evol Biol 286 875 884 16114069
18. WM Stadler 2005 Targeted agents for the treatment of advanced renal cell carcinoma Cancer 104 2323 2333 10.1002/cncr.21453 1:CAS:528:DC%2BD2MXhtlWgt7nF 16240452 (Pubitemid 41691552)
19. P An H Lei J Zhang, et al. 2004 Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library Int J Cancer 111 165 173 10.1002/ijc.20214 1:CAS:528: DC%2BD2cXlvFWnsL4%3D 15197767 (Pubitemid 38924692)
20. V Hanrahan MJ Currie SP Gunningham, et al. 2003 The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression J Pathol 200 183 194 10.1002/path.1339 1:CAS:528:DC%2BD3sXlsFeisro%3D 12754739 (Pubitemid 36748027)
21. N Simiantonaki M Taxeidis C Jayasinghe CJ Kirkpatrick 2007 Epithelial expression of VEGF receptors in colorectal carcinomas and their relationship to metastatic status Anticancer Res 27 3245 3250 17970067
22. D Witte A Thomas N Ali N Carlson M Younes 2002 Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma Anticancer Res 22 1463 1466 1:CAS:528: DC%2BD38XmsFWltbw%3D 12168824
23. TC Wehler K Frerichs C Graf, et al. 2008 PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy Oncol Rep 19 697 704 1:CAS:528:DC%2BD1cXjs1elsrk%3D 18288404
24. JP Spano C Lagorce D Atlan, et al. 2005 Impact of EGFR expression on colorectal cancer patient prognosis and survival Ann Oncol 16 102 108 10.1093/annonc/mdi006 15598946 (Pubitemid 40124486)
25. A Gamboa-Dominguez C Dominguez-Fonseca L Quintanilla-Martinez, et al. 2004 Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system Mod Pathol 17 579 587 10.1038/modpathol.3800085 1:CAS:528:DC%2BD2cXmsVOitro%3D 15073595 (Pubitemid 38868426)
26. R Kopp E Rothbauer M Ruge, et al. 2003 Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options Recent Results Cancer Res 162 115 132 1:CAS:528:DC%2BD3sXmsFOgsrk%3D 12790326
27. U Linnemann CC Schimanski C Gebhardt MR Berger 2004 Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations Int J Colorectal Dis 19 380 386 10.1007/s00384-003-0555-3 14634776 (Pubitemid 38868306)